Medline ® Abstract for Reference 38
of 'Classification and evaluation of myoclonus'
38
TI
A novel locus for inherited myoclonus-dystonia on 18p11.
AU
Grimes DA, Han F, Lang AE, St George-Hyssop P, Racacho L, Bulman DE
SO
Neurology. 2002;59(8):1183.
OBJECTIVE:
Inherited myoclonus-dystonia (IMD) is a new term for an autosomal dominant disorder characterized by myoclonus and dystonia. Recently, IMD was linked to a region on chromosome 11q23 with two different mutations identified in the D2 dopamine receptor gene and linked to chromosome 7q with five different loss-of-function mutations identified in the epsilon-sarcoglycan gene.
METHODS:
These two regions and genes were excluded in a large Canadian family with IMD in whom 13 individuals are affected. A 25-cM genome scan of this large family with 32 individuals was performed.
RESULTS:
Two-point linkage analysis revealed a maximum lod score of 3.5 (recombination fraction 0.00; affected only) for the microsatellite marker GATA185C06-18 and a multipoint lod score of 3.9 across the 18p11 region. Haplotype analysis demonstrates that all the affected individuals shared a common haplotype between markers D18S1132 and D18S843 that defines the disease gene within a span of 16.9 cM.
CONCLUSIONS:
These findingsindicate that a novel IMD gene exists on chromosome 18p11.
AD
Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa, Canada. dagrimes@ottawahospital.on.ca
PMID